{"id":"https://openalex.org/W2549528306","doi":"https://doi.org/10.1093/neuonc/now262","title":"Molecular profiling optimizes the treatment of low-grade glioma","display_name":"Molecular profiling optimizes the treatment of low-grade glioma","publication_year":2016,"publication_date":"2016-10-11","ids":{"openalex":"https://openalex.org/W2549528306","doi":"https://doi.org/10.1093/neuonc/now262","mag":"2549528306","pmid":"https://pubmed.ncbi.nlm.nih.gov/27880641","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5744246"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/now262","doi":"https://doi.org/10.1093/neuonc/now262","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/now262","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/18/12/1593/22933978/now262.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/18/12/1593/22933978/now262.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023905352","display_name":"David Schiff","orcid":"https://orcid.org/0000-0002-1896-2502","observed_orcids":["https://orcid.org/0000-0002-1896-2502","https://orcid.org/0000-0003-1561-9220"]},"institutions":[{"id":"https://openalex.org/I4390039272","display_name":"University of Virginia Cancer Center","ror":"https://ror.org/04w75nz84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039272"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David Schiff","raw_affiliation_strings":["University of Virginia Neuro-Oncology Center, Charlottesville, Virginia davidschiff@virginia.edu","University of Virginia Neuro-Oncology Center, Charlottesville, Virginia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Virginia Neuro-Oncology Center, Charlottesville, Virginia davidschiff@virginia.edu","institution_ids":["https://openalex.org/I51556381"]},{"raw_affiliation_string":"University of Virginia Neuro-Oncology Center, Charlottesville, Virginia","institution_ids":["https://openalex.org/I4390039272","https://openalex.org/I51556381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5023905352"],"corresponding_institution_ids":["https://openalex.org/I4390039272","https://openalex.org/I51556381"],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"12","first_page":"1593","last_page":"1594"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/low-grade-glioma","display_name":"low-grade glioma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.699999988079071},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7239999771118164},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.7919999957084656},{"id":"https://openalex.org/keywords/idh-mutation","display_name":"IDH mutation","score":0.9559999704360962},{"id":"https://openalex.org/keywords/chromosome-1p-loss","display_name":"chromosome 1p deletion","score":0.8059999942779541},{"id":"https://openalex.org/keywords/molecular-stratification","display_name":"molecular stratification","score":0.8899999856948853},{"id":"https://openalex.org/keywords/neurocognitive-decline","display_name":"neurocognitive decline","score":0.6420000195503235},{"id":"https://openalex.org/keywords/molecular-profiling","display_name":"molecular profiling","score":0.36399999260902405},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.48100000619888306},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.44999998807907104},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8479999899864197}],"concepts":[{"id":"https://openalex.org/C187191949","wikidata":"https://www.wikidata.org/wiki/Q1138496","display_name":"Profiling (computer programming)","level":2,"score":0.7540184259414673},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.6118975281715393},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3295685052871704},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3236796259880066},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28449952602386475},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.284128874540329},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1401957869529724},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.05348971486091614}],"mesh":[{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/neuonc/now262","doi":"https://doi.org/10.1093/neuonc/now262","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/now262","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/18/12/1593/22933978/now262.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4667730","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5744246","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5744246","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5744246","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"},{"id":"pmid:27880641","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27880641","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-oncology","raw_type":"Editorial"}],"best_oa_location":{"id":"doi:10.1093/neuonc/now262","doi":"https://doi.org/10.1093/neuonc/now262","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/now262","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/18/12/1593/22933978/now262.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2549528306.pdf","grobid_xml":"https://content.openalex.org/works/W2549528306.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W571060166","https://openalex.org/W1812256879","https://openalex.org/W2000443501","https://openalex.org/W2115276344","https://openalex.org/W2119838967","https://openalex.org/W2171212160","https://openalex.org/W2313086999","https://openalex.org/W2505666614","https://openalex.org/W2526176932"],"related_works":["https://openalex.org/W2505666614","https://openalex.org/W2508919572","https://openalex.org/W4242867217","https://openalex.org/W7167035182","https://openalex.org/W4250822138","https://openalex.org/W3112583791","https://openalex.org/W2591308505","https://openalex.org/W1968301918","https://openalex.org/W2899995714","https://openalex.org/W2523766290"],"abstract_inverted_index":{"Multiple":[0],"developments":[1],"converged":[2],"in":[3,53,77,89,93,99,304,327,365,378,391,432,447,509,644,723,757,831,942],"the":[4,9,78,100,142,146,204,267,271,280,292,317,324,362,384,398,417,420,425,493,510,536,551,594,602,640,665,689,726,739,748,776,843,847,871,896,924,929],"early":[5,715,932],"2000s":[6],"to":[7,20,111,160,165,300,322,501,518,549,700,721,764,808,838,927,936],"support":[8,440],"initiation":[10],"of":[11,29,38,51,81,144,150,168,175,181,203,211,217,228,270,274,319,340,347,371,389,397,419,428,442,464,496,538,542,604,620,647,649,673,703,717,750,778,785,802,846,874,880,884,895,909,915,920,934],"a":[12,30,47,310,337,433,599,610,628,632,789,943],"phase":[13],"III":[14],"clinical":[15,247],"trial":[16,45,295,499,552],"comparing":[17],"dose-dense":[18,84,169],"temozolomide":[19,85,135,170,330,511,565,582,615,692,839],"standard":[21,64,161,246],"fractionated":[22],"radiotherapy":[23,44,92,105],"for":[24,34,106,251,309,407,479,492,616,733,775,793,869,887],"low-grade":[25],"glioma":[26],"(LGG).":[27],"Results":[28],"prior":[31],"European":[32],"Organisation":[33],"Research":[35],"and":[36,83,113,129,140,148,230,259,290,299,383,444,462,484,566,653,675,684,691,796,823],"Treatment":[37],"Cancer":[39,456],"(EORTC)":[40],"\u201cearly":[41],"versus":[42,163],"delayed\u201d":[43],"confirmed":[46],"relatively":[48,561],"modest":[49],"benefit":[50,88,792,827],"radiation":[52,65,125,151,162,332,519,567,585,608,690,718,765,795,821,876],"improving":[54],"progression-free":[55],"survival":[56,61,791,888],"(PFS)1;":[57],"moreover,":[58,705],"median":[59,507],"overall":[60],"(OS)":[62],"with":[63,74,91,123,157,225,329,367,416,451,558,564,581,584,631,760,812,863],"was":[66,188,223,256,264,291,482,515,598,625,912],"underwhelming.":[67],"Temozolomide":[68],"had":[69,86,136,403,468,560,578],"shown":[70],"single":[71],"agent":[72],"activity":[73],"encouraging":[75],"PFS":[76,328,413,508,563,580,633,637],"first-line":[79,134],"treatment":[80,184,613],"LGG,2,3":[82],"demonstrated":[87,788],"conjunction":[90],"glioblastoma.":[94],"Furthermore,":[95],"although":[96],"neurocognitive":[97,120,231,651,872],"dysfunction":[98],"first":[101,293],"few":[102],"years":[103,702],"after":[104],"LGG":[107,205,283,350,761],"appeared":[108],"principally":[109],"attributable":[110],"tumor":[112,711],"anti-epileptic":[114],"drugs,":[115],"long-term":[116],"survivors":[117],"often":[118],"manifested":[119],"decline":[121],"even":[122],"modern":[124],"delivery":[126],"techniques,":[127],"dose,":[128],"fraction":[130],"size.":[131],"In":[132,208,572],"contrast,":[133,573],"no":[137,473,686],"known":[138],"neurotoxicity":[139],"afforded":[141],"possibility":[143],"delaying":[145],"administration":[147],"risks":[149],"therapy.":[152],"EORTC":[153,277,401,623,779,803,848,885],"22033-26033":[154,278,402,624,804,886],"randomized":[155,294,763],"patients":[156,351,759,832],"\u201chigh-risk\u201d":[158],"LGGs":[159,526,935],"up":[164],"one":[166,907],"year":[167],"(75":[171],"mg/m2":[172],"days":[173],"1\u201321":[174],"each":[176],"28-day":[177],"cycle).":[178],"The":[179,220,412,455,781],"definition":[180],"\u201chigh-risk,\u201d":[182],"justifying":[183],"rather":[185],"than":[186,614],"observation,":[187,773],"either":[189,769],"(i)":[190],"age":[191],">40,":[192],"(ii)":[193],"tumor-related":[194],"symptoms":[195],"or":[196,199,476,540,772,866],"uncontrolled":[197],"seizures,":[198],"(iii)":[200],"radiographic":[201,218,636],"progression":[202],"under":[206],"observation.":[207],"fact,":[209],">60%":[210],"subjects":[212],"went":[213],"on":[214,400,535,738,842],"study":[215,630,727,897],"because":[216],"progression.":[219,712],"primary":[221,504,634],"endpoint":[222,643],"PFS,":[224],"OS,":[226],"quality":[227,648,672],"life,":[229,650],"function":[232,677],"as":[233,506,627,678,841,906],"measured":[234],"by":[235,554,680,768],"Mini-Mental":[236,681],"State":[237,682],"Examination":[238,683],"secondary":[239],"endpoints.":[240],"Chromosome":[241],"1p":[242],"deletion":[243],"status":[244,255,263,446],"complemented":[245],"stratification":[248,303],"factors.":[249],"Analysis":[250],"MGMT":[252,469,480,487],"promoter":[253,470],"methylation":[254],"built":[257],"in,":[258],"IDH":[260,392,443],"mutational":[261],"(IDHmt)":[262],"added":[265],"following":[266,710],"2009":[268],"discovery":[269],"seminal":[272],"nature":[273],"this":[275,305,341,410,429,597,605,617,698,826,954],"mutation.":[276],"represents":[279,336],"largest":[281],"prospective":[282],"trial,":[284],"met":[285],"its":[286,503,734],"accrual":[287],"goals":[288],"quickly,":[289],"testing":[296,481,488],"chemotherapy":[297,771],"alone":[298,840],"incorporate":[301],"molecular":[302,355,430,555,918],"entity\u2014all":[306],"remarkable":[307],"achievements":[308],"rare":[311],"entity.":[312],"Its":[313],"publication":[314],"now":[315],"reflects":[316],"occurrence":[318],"sufficient":[320],"events":[321],"exclude":[323],"posited":[325],"improvement":[326],"over":[331],"therapy.4":[333],"Molecular":[334],"analysis":[335,699],"major":[338],"strength":[339,603],"trial.":[342],"Several":[343],"recent":[344],"retrospective":[345,422],"studies":[346],"heterogeneously":[348],"treated":[349,435],"suggested":[352],"that":[353,388,524,596,799,913,931],"limited":[354,697],"profiling":[356],"identified":[357],"3":[358],"distinct":[359,532],"prognostic":[360,426,477],"groups:":[361],"best":[363],"outcome":[364,377,386],"tumors":[366,380,399,461,467,575,834,861,868],"1p/19q":[368,445,543,864],"codeletion":[369,559,577],"(all":[370],"which":[372,758,870],"are":[373,655,743,858],"IDHmt),":[374],"an":[375,853,903],"intermediate":[376],"IDHmt":[379,466,525,574],"lacking":[381,576],"codeletion,":[382,544],"poorest":[385],"(approaching":[387],"glioblastoma)":[390],"wild-type":[393],"(wt)":[394],"tumors.5,6":[395],"Two-thirds":[396],"adequate":[404],"tissue":[405,916],"available":[406],"classification":[408,431,919],"into":[409,530],"system.":[411],"results":[414,418,453,553,749,784,925,952],"align":[415],"previous":[421,452],"studies,":[423],"confirming":[424],"value":[427],"homogeneously":[434],"population.":[436],"These":[437],"findings":[438],"strongly":[439],"determination":[441],"all":[448,459],"LGGs.":[449,497,621],"Consistent":[450],"from":[454,953],"Genome":[457],"Atlas,6":[458],"codeleted":[460],"86%":[463],"non-codeleted,":[465],"hypermethylation.":[471],"Thus,":[472,713],"independent":[474],"predictive":[475],"utility":[478],"found,":[483],"at":[485],"present":[486],"should":[489],"be":[490,528,806,829],"reserved":[491],"IDHwt":[494],"subset":[495,619],"This":[498],"failed":[500],"meet":[502],"endpoint,":[505,635],"arm":[512,845],"(39":[513],"mo)":[514],"not":[516,639,660,708,730],"superior":[517],"therapy":[520,719,766,822,939],"(46":[521],"mo).":[522,571],"Recognizing":[523],"can":[527],"separated":[529],"2":[531],"biological":[533],"groups":[534],"basis":[537],"presence":[539],"absence":[541],"it":[545,851],"is":[546,609,638,818],"more":[547,611,656],"instructive":[548],"examine":[550],"subtype.":[556],"Subjects":[557],"similar":[562],"(55.0":[568],"vs":[569,587],"61.6":[570],"inferior":[579],"compared":[583,811],"(36.0":[586],"55.4":[588],"mo,":[589],"P":[590],"=":[591],".004).":[592],"With":[593],"caveat":[595],"subgroup":[600],"analysis,":[601],"finding":[606],"suggests":[607],"effective":[612],"intermediate-prognosis":[618],"Although":[622],"designed":[626],"superiority":[629],"most":[641,740],"important":[642],"LGG:":[645],"preservation":[646],"function,":[652],"OS":[654,658,810],"meaningful.":[657],"has":[659,899],"yet":[661,890],"been":[662],"reported":[663],"given":[664],"short":[666],"follow-up.":[667],"An":[668],"accompanying":[669],"manuscript":[670],"analyzed":[671],"life":[674],"cognitive":[676],"assessed":[679],"found":[685],"difference":[687],"between":[688,820],"groups.7":[693],"However,":[694],"missing":[695],"data":[696,706,737],"three":[701],"follow-up;":[704],"were":[707,720,762],"collected":[709],"if":[714,816],"use":[716],"result":[722,941],"delayed":[724],"neurotoxicity,":[725],"design":[728],"may":[729,828,940],"have":[731],"allowed":[732],"detection.":[735],"Consequently,":[736],"critical":[741],"endpoints":[742],"still":[744],"lacking.":[745],"What":[746],"do":[747],"Radiation":[751],"Therapy":[752],"Oncology":[753],"Group":[754],"(RTOG)":[755],"9802,":[756],"followed":[767],"procarbazine/lomustine/vincristine":[770],"mean":[774],"relevance":[777],"22033-26033?":[780],"recently":[782],"published":[783],"RTOG":[786,910],"98028":[787],"substantial":[790],"combined":[794,813],"chemotherapy,":[797],"suggesting":[798],"both":[800],"arms":[801],"would":[805],"likely":[807],"compromise":[809,879],"radiochemotherapy.":[814],"Moreover,":[815],"there":[817,857],"synergy":[819],"alkylating":[824],"agents,":[825],"lost":[830],"whose":[833],"received":[835],"prolonged":[836,937],"exposure":[837,933],"investigational":[844],"study.":[849,956],"Nonetheless,":[850],"remains":[852],"open":[854],"question":[855],"whether":[856],"particularly":[859],"chemosensitive":[860],"(eg,":[862],"codeletion)":[865],"large":[867],"benefits":[873],"deferring":[875],"justify":[877],"potential":[878],"OS.":[881],"Further":[882],"follow-up":[883],"(not":[889],"reported,":[891],"since":[892],"only":[893],"one-quarter":[894],"population":[898],"died)":[900],"will":[901],"represent":[902],"invaluable":[904],"contribution,":[905],"shortcoming":[908],"9802":[911],"lack":[914],"precluded":[917],"tumors.":[921],"To":[922],"date,":[923],"appear":[926],"alleviate":[928],"concern":[930],"alkylator":[938],"clinically":[944],"significant":[945],"hypermutator":[946],"syndrome.9":[947],"We":[948],"eagerly":[949],"await":[950],"further":[951],"landmark":[955]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-11-30T00:00:00"}